Oriola Corporation B (OKDBV.HE) Financials
OKDBV.HE Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 934.7 million | 763.4 million |
| 2023-09-30 | 922.4 million | 748.3 million |
| 2023-06-30 | 931.5 million | 737.6 million |
| 2023-03-31 | 952.4 million | 737.7 million |
OKDBV.HE Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 21.8 million | ? |
| 2023-09-30 | 9.3 million | ? |
| 2023-06-30 | 18.0 million | ? |
| 2023-03-31 | -43.1 million | ? |
OKDBV.HE Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | -2.8 million |
| 2023-09-30 | -20.2 million |
| 2023-06-30 | 1.2 million |
| 2023-03-31 | 1.1 million |
OKDBV.HE Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | - | - | 8.9 million |
| 2023-09-30 | 130.3 million | 36.3 million | 7.9 million |
| 2023-06-30 | 128.4 million | 39.1 million | 10.2 million |
| 2023-03-31 | 119.1 million | 67.6 million | 12.9 million |
OKDBV.HE Shares Outstanding
OKDBV.HE Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 1.1 million | - | - | - |
| 2023-09-30 | 2.5 million | - | 11.5 million | - |
| 2023-06-30 | 1.2 million | - | 14.5 million | - |
| 2023-03-31 | 500000 | - | 14.5 million | - |
OKDBV.HE Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 402.9 million | 362.7 million |
| 2023-09-30 | 352.6 million | 315.5 million |
| 2023-06-30 | 383.6 million | 343.3 million |
| 2023-03-31 | 354.7 million | 312.7 million |
OKDBV.HE
Price: €0.95
Dividend Yield: 0.07%
Forward Dividend Yield: 7.35%
Payout Ratio: -63.64%
Dividend Per Share: 0.07 EUR
Earnings Per Share: -0.11 EUR
P/E Ratio: -7.33
Exchange: HEL
Sector: Healthcare
Industry: Pharmaceutical Retailers
Market Capitalization: 200.5 million
Average Dividend Frequency: 1
Years Paying Dividends: 9
DGR3: 5.56%
DGR5: 3.33%